Search

everythinglearnresearchcommunity

for

Search:↓

A 6-year-old girl with alopecia universalis regrew most of her hair after treatment with simvastatin/ezetimibe, minoxidil, and prednisolone.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The rash resolved after stopping ponatinib.

Surgery is the main treatment for liver hydatidosis, but has risks; albendazole is the most effective drug but can have side effects.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

People with more than 11 skin tags, especially on the thigh, neck, or armpit, may have a higher chance of metabolic syndrome.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Consider benefits and risks of new alopecia treatments for safety.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Washing test helps identify hair loss type, low iron levels significant.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

To treat tinea capitis in children, oral antifungal medication is necessary, with newer drugs offering shorter treatment times than the traditional griseofulvin.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Acne is a chronic skin condition not caused by poor hygiene or diet, and it requires long-term treatment and patient education.

Skin tags in obese individuals may indicate higher cardiovascular risk.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Early diagnosis and personalized treatments are crucial for better hair loss management.

Some moles can disappear naturally, maintenance therapy for Stage 1 mycosis fungoides may not be necessary, allergic skin reactions in children are rising, weekly methotrexate for psoriasis is more effective than daily, long-term finasteride use improves hair growth with few side effects, and petrolatum improves UV therapy for psoriasis.

Mast cells play a significant role in hair loss conditions like male pattern hair loss and alopecia areata.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.